SIOP Europe shared a post on Facebook:
“Unlocking new possibilities with what we already have.
Did you know that many existing drugs could be repurposed for childhood cancer treatment? But academic research struggles to make these medicines available due to regulatory and industry barriers.
We advocate for academic-led drug repurposing to be recognised and supported in the EU Pharma package to ensure lifesaving medicines reach children in need.
What can you do? Engage with us:
Share these posts to amplify our message
Use EUPharma4Children, EUPharmaAdvocacy Series, and Childhood Cancer to join the conversation
Visit our dedicated webpage.”
More posts featuring SIOP Europe